drugset / Trial / NCT03817684
Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Randomized, Double-blind, Placebo Controlled, 3-Arm Parallel Design Study to Evaluate the Effects of BPN14770 in Patients with Early Alzheimer's Disease
Timeline
- Start
- 2019-04-30
- Primary completion
- 2020-02-04
- Completion
- 2020-02-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | zatolmilast | Small molecule | 10 mg | — |
| Subject | zatolmilast | Small molecule | 25 mg | — |